Suggestion for a new grading scale for radiation induced pneumonitis based on radiological findings of computerized tomography: Correlation with clinical and radiotherapeutic parameters in lung cancer patients

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 2717-2722

  Kouloulias, Vassilios ^a   Zygogianni, Anna ^a   Efstathopoulos, Efstathios ^a   Victoria, Oikonomopoulou ^a   Christos, Antypas ^a   Pantelis, Karaiskos ^b   Koutoulidis, Vassilios ^a   Kouvaris, John ^a   Sandilos, Panagiotis ^a,b   Varela, Maria ^c   Aytas, Ilknur ^d   Gouliamos, Athanasios ^a   Kelekis, Nikolaos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Ygeia Hospital   (Greece)

^c 251 Air Force Hospital   (Greece)

^d ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Computerized tomography; Pneumonitis; Radiotherapy; Thoracic imaging; Toxicity grading scale

Indexed keywords

AGED; ATELECTASIS; CARCINOMA, NON-SMALL-CELL LUNG; CLASSIFICATION; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FIBROSIS; HUMAN; LUNG FUNCTION TEST; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RADIATION PNEUMONITIS; RADIOGRAPHY; SMOKING;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FIBROSIS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY ATELECTASIS; RADIATION PNEUMONITIS; RESPIRATORY FUNCTION TESTS; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84880339073     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.2717     Document Type: Article

References (41)

1. Abratt RP, Willcox PA. (1995). The effect of irradiation on lung function and perfusion in patients with lung cancer. Int J Radiat Oncol Biol Phys, 31, 915-9.
2. Aoki T, Nagata Y, Negoro Y, et al. (2004). Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance. Radiology, 230, 101-8.
3. Barriger B, Forquer J, Brabham J, et al. (2010). A dose volume analysis of radiation pneumonitis in non small cell lung cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys, 82, 457-62.
4. Borst GR, De Jaeger K, Belderbos JS, et al. (2005). Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival. Int J Radiat Oncol Biol Phys, 62, 639-44.
5. Bucci MK, Bevan A, Roach M 3rd. (2005). Advances in radiation therapy. Conventional to 3D, to IMRT, to 4D, and Beyond. CA Cancer J Clin, 55, 117-34.
6. Choi NC, Kanarek DJ. (1994). Toxicity of thoracic radiotherapy on pulmonary function in lung cancer. Lung Cancer, 10, 219-30.
7. Claude L, Pérol D, Ginestet C, et al. (2005). A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol, 75, 120-1.
8. de Cos Escuín JS, Delgado IU, Rodríguez JC, et al. (2007). Stage IIIA and IIIB non-small cell lung cancer: results of chemotherapy combined with radiation therapy and analysis of prognostic factors. Arch Bronconeumol, 43, 358-65.
9. Ghafoori P, Marks LB, Vujaskovic Z, et al. (2008). Radiationinduced lung injury. Assessment, management, and prevention. Oncology, 22, 37-47.
10. Graham MV, Purdy JA, Emami B, et al. (1999). Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys, 45, 323-9.
11. Groover TA, Christle AC, Merritt EA. (1922). Observations on the use of the copper filter in the roentgen treatment of deepsated malignancies. South Med J, 15, 440-4.
12. Gross NJ. (1977). Pulmonary effects of radiation therapy. Ann Intern Med, 86, 81-92.
13. Guckenberger M, Baier K, Polat B, et al. (2010). Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. Radiother Oncol, 97, 65-70.
14. Hernando ML, Marks LB, Bentel GC, et al. (2001). Radiationinduced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys, 51, 650-9.
15. Ikezoe J, Takashima S, Morimoto S, et al. (1988). CT appearance of acute radiation-induced injury in the lung. Am J Roentgenol, 150, 765-70.
16. Inoue A, Kunitoh H, Sekine I, et al. (2001). Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis. Int J Radiat Oncol Biol Phys, 49, 649-55.
17. Kimura T, Togami T, Takashima H, et al. (2012). Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema. Br J Radiol, 85, 135-41.
18. Kocak Z, Borst GR, Zeng J, et al. (2007). Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis. Int J Radiat Oncol Biol Phys, 67, 178-86.
19. Koenig TR, Munden RF, Erasmus JJ, et al. (2002). Radiation injury of the lung after three-dimensional conformal radiation therapy. Am J Roentgenol, 178, 1383-8.
20. Kong FM, Hayman JA, Griffith KA, et al. (2006). Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys, 65, 1075-86.
21. Kouvaris JR, Kouloulias VE, Vlahos LJ. (2007). Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist, 12, 738-47.
22. Kumar G, Rawat S, Puri A, et al. (2012). Analysis of dose-volume parameters predicting radiation pneumonitis in patients with esophageal cancer treated with 3D-conformal radiation therapy or IMRT. Jpn J Radiol, 30, 18-24.
23. Libshitz HJ, Shuman LS. (1984). Radiation-induced pulmonary change. CT findings. J Comput Assist Tomogr, 8, 15-9.
24. Madani I, De Ruyck K, Goeminne H, et al. (2007). Predicting risk of radiation-induced lung injury. J Thorac Oncol, 2, 864-74.
25. Mehta V. (2005). Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys, 63, 5-24
26. Miller KL, Shafman TD, Marks LB. (2004). A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer. Semin Radiat Oncol, 14, 298-307.
27. Miller KL, Zhou SM, Barrier RC, et al. (2003). Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys, 56, 611-5.
28. Morarji K, Fowler A, Vinod SK, et al. (2012). Impact of FDGPET on lung cancer delineation for radiotherapy. J Med Imaging Radiat Oncol, 56, 195-203.
29. Myers JN, O'Neil KM, Walsh TE, et al. (2005). The pulmonary status of patients with limited-stage small cell lung cancer 15 years after treatment with chemotherapy and chest irradiation. Chest, 128, 3261-8.
30. Piotrowski T, Matecka-Nowak M, Milecki P. (2005). Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after threedimensional conformal radiotherapy. Neoplasma, 52, 56-62.
31. Ramella S, Trodella L, Mineo TC, et al. (2010). Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy. Int J Radiat Oncol Biol Phys, 76, 110-5.
32. Robnett TJ, Machtay M, Vines EF, et al. (2000). Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys, 48, 89-94.
33. Roswitt B, White DC. (1977). Severe radiation injuries of the lung. Am J Roentgenol, 12, 127-36.
34. Salinas FV, Winterbauer RH. (1995). Radiation pneumonitis: a mimic of infectious pneumonitis. Semin Respir Infect, 10, 143-53.
35. Schallenkamp JM, Miller RC, Brinkmann DH, Foote T, Garces YI. (2007). Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates. Int J Radiat Oncol Biol Phys, 67, 410-6.
36. Tarbell NJ, Thompson L, Mauch P. (1990). Thoracic radiation on Hodgkin's disease: disease control and long-term complications. Int J Radiat Oncol Biol Phys, 18, 275-81.
37. Tsoutsou PG, Koukourakis MI. (2006). Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys, 66, 1281-93.
38. Tsujino K, Hirota S, Endo M, et al. (2003). Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys, 55, 110-5.
39. Uno T, Isobe K, Kawakami H, et al. (2006). Dose-volume factors predicting radiation pneumonitis in patients receiving salvage radiotherapy for postlobectomy locoregional recurrent non-small-cell lung cancer. Int J Clin Oncol, 11, 55-9.
40. Wang ZD, Qiao YL, Tian XF, et al. (2012). Toll-like Receptor 5 Agonism Protects Mice from Radiation Pneumonitis and Pulmonary Fibrosis. Asian Pac J Cancer Prev, 13, 4763-7.
41. Zhang XJ, Sun JG, Sun J, et al. (2012). Prediction of radiation pneumonitis in lung cancer patients: a systematic review. J Cancer Res Clin Oncol, 138, 2103-16.